Wolff-Parkinson-White Syndrome: Identification and Management

Drugs

Volumn 43, Issue 2, 1992, Pages 185-200

  Gaita, Fiorenzo ^a   Giustetto, Carla ^a   Riccardi, Riccardo ^a   Brusca, Antonio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLECAINIDE; NADOLOL; PROPAFENONE;

DIAGNOSTIC TEST; DRUG CHOICE; ELECTROCARDIOGRAM; EXERCISE TEST; HEART ACCESSORY CONDUCTION PATHWAY; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART PREEXCITATION; HUMAN; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; REENTRY TACHYCARDIA; REVIEW; SUDDEN DEATH; TACHYCARDIA; WOLFF PARKINSON WHITE SYNDROME;

ARRHYTHMIA; HUMAN; WOLFF-PARKINSON-WHITE SYNDROME;

EID: 0026527362     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/00003495-199243020-00005     Document Type: Article

References (64)

1. Pre-excited reciprocating tachycardia in patients with Wolff-Parkinson-White syndrome: incidence and mechanism
2. Paroxysmal atrial fibrillation in the Wolff-Parkinson-White syndrome
3. The Wolff-Parkinson-White syndrome electrocardiogram: a follow-up study of five to twenty years
4. A comparison of the antiarrhythmic effects on AV junctional re-entrant tachycardia or oral and intravenous flecainide acetate
5. Radiofrequency ablation of supraventricular and atrioventricular tachyarrhythmias
6. Effect of proprafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up
7. Atrial fibrillation in the preexcitation syndrome
8. Syndrome de Wolff-Parkinson-White et mort subite
9. Experience with 118 consecutive patients undergoing operation for Wolff-Parkinson-White syndrome
10. Effect of exercise on ventricular response to atrial fibrillation in Wolff-Parkinson-White syndrome
11. Evaluation of noninvasive tests for identifying patients with preexcitation syndrome at risk of rapid ventricular response
12. Ventricular fibrillation: a possible mechanism of sudden death in patients with Wolff-Parkinson-White syndrome
13. Comparison of exercise and ajmaline tests with electrophysiologic study in the Wolff-Parkinson-White syndrome
14. Etude de la propafenone injectable et orale dans les rentres nodales et les voies de preexcitation ventriculaire
15. Effets de la flécainide injectable et orale chez les patients avant una voie accessoire auriculo-ventriculaire
16. Wolff-Parkinson-White syndrome: a long-term follow-up of 47 cases
17. Corrélation entre l’orientation de l’onde delta et la topographie de la pré-excitation dans le sindrome de Wolff-Par-kinson-White
18. Stress and pharmacological test as methods to identify patients with Wolff-Parkinson-White syndrome at risk of sudden death
19. Wolff-Parkinson-White syndrome: atrial vulnerability and electrophysiologic features in patients with and without atrial fibrillation
20. Relation between spontaneous atrial fibrillation and atrial vulnerability in patients with Wolff-Parkinson-White pattern
21. The preexcitation syndrome
22. Effects of exercise and isoproterenol during atrial fibrillation in patients with Wolff-Parkinson-White syndrome
23. Wolff-Parkinson-White syndrome in infants and children: a long-term follow-up study
24. Surgery for Wolff-Parkinson-White syndrome using a closed heart technique: further experience and limitations. Abstract
25. Prévalence et evolution du syndrome de Wolff-Parkinson-White dans une population de 138,048 sujets
26. Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil
27. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome
28. Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias
29. Electrocardiographic findings in 122 043 individuals
30. Flecainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy
31. Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current
32. The induction of atrial flutter and fibrillation and the termination of atrial flutter by esophageal pacing
33. Ventricular fibrillation in the Wolff-Parkinson-White syndrome
34. Ventriculr fibrillation in the Wolff-Parkinson-White syndrome
35. Intermittent preexcitation in the Wolff-Parkinson-White syndrome
36. Efficacy of proprafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up
37. Deux cas mortels de syndrome de Wolff-Parkinson-White
38. Atrial electrophysiologic properties of patients with asymptomatic Wolff-Parkinson-White
39. Preexcitation studies on criteria, prognosis and heredity
40. Unmasking of ventricular preexcitation by vagal stimulation or isoproterenol administration
41. Effects of upright posture on atrioventricular accessory pathway conduction
42. Relation between clinical presentation and induced arrhythmias in the Wolff-Parkinson-White syndrome
43. Studio elettrofisiologico in clinoed in ortostatismo dei pazienti con Wolff-Parkinson-White
44. The Wolff-Parkinson-White syndrome in infants and children: a review and a report of 28 cases
45. Digitalis in the pre-excitation syndrome: analysis during atrial fibrillation
46. Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: incidence after surgical ablation of the accessory pathway
47. Sensitivity and specificity of invasive and non-invasive tests for risk of sudden death in Wolff-Parkinson-White syndrome
48. Intravenous propafenone for termination of reentrant supraventricular tachycardia: a placebo controlled randomized, double-blind, cross-over study
49. Nonpharmacological therapy of supraventricular arrhythmias: surgery and catheter ablation techniques. Part II
50. Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use
51. Treadmill exercise testing in the Wolff-Parkinson-White syndrome
52. Mechanism of spontaneous alternation between reciprocating tachycardia and atrial flutter-fibrillation in the Wolff-Parkinson-White syndrome
53. The Wolff-Parkinson-White syndrome in infancy and childhood
54. Elements de pronostic dans le syndrome de Wolff-Parkinson-White
55. Appropriate electrophysiologic study and treatment of patients with the Wolff-Parkinson-White syndrome
56. Electrical catheter ablation of accessory pathways: technique and result in 215 patients. Cardiostim 90 7th International Congress. Abstract
57. Wolff-Parkinson-White syndrome. Diagnosis, arrhythmias and identification of the high risk patient
58. Use of ajmaline in patients with the Wolff-Parkinson-White syndrome to disclose short refractory period of the accessory pathway
59. Use of procainamide in patients with the Wolff-Parkinson-White syndrome to disclose short refractory period of the accessory pathway
60. Effect of isoproterenol on the anterograde refractory period of the accessory pathway in patients with Wolff-Parkinson-White syndrome
61. Wolff-Parkinson-White syndrome and atrial fibrillation: relation between refractory period of accessory pathway and ventricular rate during atrial fibrillation
62. Sindrome di Wolff-Parkinson-White: esperienza di trattamento chirurgico in 100 pazienti